Hypoglycemia as a side eff ect of infantile hemangioma treatment with propranolol: three case reports
DOI:
https://doi.org/10.13112/PC.2014.55Keywords:
hypoglycemia, hemangioma, propranolol, infantAbstract
Therapy of choice for complicated hemangiomas in infancy is orally administered propranolol in a dose of 1-3 mg/kg/day. We reporton two patients who developed symptomatic hypoglycemia and one patient experiencing seizures most likely associated withhypoglycemia. Oral propranolol therapy for the treatment of infantile hemangioma was administered to all three patients. Althoughpropranolol is used in other indications and seems to be a safe drug, due to its non-selectiveness it is necessary to recognize thepossible less common side eff ects such as hypoglycemia, especially when administered for a new indication, such as treatment ofinfantile hemangiomas in the stage of proliferative growth.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Paediatria Croatica, authors retain the copyright to their work and grant others the right to use, reproduce, and share their research articles in accordance with the Creative Commons Attribution License (CC BY 4.0), which allows others to distribute and build upon the work as long as they credit the author for the original creation.
